covid 19 News and Research

RSS

The Elton John AIDS Foundation: a powerful force in the end to the AIDS epidemic

To commemorate World AIDS Day, News Medical spoke to Anne Aslett, Chief Executive Officer of the Elton John AIDS Foundation, about the work of the foundation and the actions required to address inequalities and help end AIDS.

1 Dec 2022

UW School of Medicine solidifies partnership with Lummi Nation to open more training opportunities

The University of Washington School of Medicine has solidified a partnership with the Lummi Nation to teach medical students and trainees at the Lummi Tribal Health Center in Bellingham, Wash.

30 Nov 2022

Study provides a framework to guide the development of variant-resistant SARS-CoV-2 vaccines

Latest research findings show that vaccine-elicited neutralizing antibodies against SARS-CoV-2 are mostly directed against one of the two main domains of the viral entry machinery.

30 Nov 2022

SARS-CoV-2 can cause hyperglycemia in cats

In a recent study published in The Journal of Infectious Diseases, researchers explored the association between severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and hyperglycemia in cats.

30 Nov 2022

Women having a higher BMI more likely to experience long Covid

Overweight women are more likely to experience symptoms of long Covid according to new research from the University of East Anglia.

30 Nov 2022

Prenatal intervention benefits mothers' mental health up to eight years later

A low-cost, prenatal intervention benefits mothers' mental health up to eight years later, a new UC San Francisco study finds.

30 Nov 2022

Detection of early-formed, antigen-specific clones in SARS-CoV-2-reactive B cells after longitudinal analysis

Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2), the causal agent of the coronavirus disease 2019 (COVID-19) pandemic, has globally infected more than 639 million individuals and claimed over 6.6 million lives. Despite the rapid commencement of COVID-19 vaccination programs in most countries across the world, the virus has remained in circulation.

30 Nov 2022

Phase 2/3 clinical trial shows that Clover’s vaccine candidate reduces household transmission of SARS-CoV-2

Clover Biopharmaceuticals, Ltd., a global clinical-stage biotechnology company developing novel vaccines and biologic therapeutics, and the International Vaccine Institute, an international nonprofit organization devoted to providing vaccines critical to global public health and based in Seoul, Korea, today announced that Clinical Infectious Diseases has published additional data from SPECTRA, a global Phase 2/3 clinical trial, that showed vaccination with SCB-2019 (CpG 1018/Alum) reduced the risk of transmitting SARS-CoV-2 infection to household members, compared to placebo participants.

30 Nov 2022

Fingerprint-embedding framework can help find novel drug candidates

Researchers have developed a new computer framework that holds promise in the work to discover new drugs. Their framework uses an artificial intelligence method called convolutional neural network to provide global information about potential novel drug candidates.

30 Nov 2022

Australian researchers unearth a new form of antimicrobial resistance

Australian researchers have uncovered a new form of antimicrobial resistance (AMR) – undetectable using traditional laboratory testing methods – in a discovery set to challenge existing efforts to monitor and tackle one of the world's greatest health threats.

30 Nov 2022

Plasma from vaccinated and COVID-19 convalescent subjects as passive immunotherapy against the new Omicron BQ.1.1, XBB, and BF.7 variants

Researchers systematically reviewed SARS-CoV-2 Omicron BQ.1.1 neutralization data from individual patient samples.

30 Nov 2022

Study suggests persistent immune activation and long COVID correlate independently with severe COVID-19

Researchers investigated whether severe COVID-19 patients exhibited inflammation and immune activation three months after hospitalization and explored the associations among COVID-19 severity, long COVID, and immune activation.

30 Nov 2022

Fragment crystallizable receptor-effector functions as a key correlate for pan-sarbecovirus vaccine development

Researchers elucidated pan-sarbecovirus immune protection mechanisms by utilizing a Venezuelan equine encephalitis virus-vectored vaccine panel that covered bat strains to human strains.

30 Nov 2022

Broadly cross-reactive antibodies that protect from SARS-CoV-2 variants are revealed by virus coldspot-driven discovery

A recent study identified neutralizing antibodies against conserved SARS-CoV-2 epitopes.

30 Nov 2022

£12 million awarded to innovative UK regulators to help drive technology and personalized medicine

Science Minister George Freeman has today (30 November) awarded up to £12 million to UK regulators to help drive forward innovation, remove red tape and establish the UK as world leader in technologies of the future - from AI to help treat rare diseases, to drones monitoring safety on construction sites.

30 Nov 2022

The antibody resistance profile and viral receptor binding affinity of SARS-CoV-2 Omicron BQ.1, BQ.1.1, XBB, and XBB.1 subvariants

Researchers investigated the neutralizing antibody titers against the newly emergent BQ.1, BQ.1.1, XBB, and XBB.1 SARS-CoV-2 Omicron subvariants using sera from individuals with primary and booster COVID-19 vaccinations and previous SARS-CoV-2 infections.

30 Nov 2022

covid 19 News and Research

The Elton John AIDS Foundation: a powerful force in the end to the AIDS epidemic

UW School of Medicine solidifies partnership with Lummi Nation to open more training opportunities

Study provides a framework to guide the development of variant-resistant SARS-CoV-2 vaccines

SARS-CoV-2 can cause hyperglycemia in cats

Women having a higher BMI more likely to experience long Covid

Prenatal intervention benefits mothers' mental health up to eight years later

Detection of early-formed, antigen-specific clones in SARS-CoV-2-reactive B cells after longitudinal analysis

Phase 2/3 clinical trial shows that Clover’s vaccine candidate reduces household transmission of SARS-CoV-2

Fingerprint-embedding framework can help find novel drug candidates

Australian researchers unearth a new form of antimicrobial resistance

Plasma from vaccinated and COVID-19 convalescent subjects as passive immunotherapy against the new Omicron BQ.1.1, XBB, and BF.7 variants

Study suggests persistent immune activation and long COVID correlate independently with severe COVID-19

Fragment crystallizable receptor-effector functions as a key correlate for pan-sarbecovirus vaccine development

Broadly cross-reactive antibodies that protect from SARS-CoV-2 variants are revealed by virus coldspot-driven discovery

£12 million awarded to innovative UK regulators to help drive technology and personalized medicine

The antibody resistance profile and viral receptor binding affinity of SARS-CoV-2 Omicron BQ.1, BQ.1.1, XBB, and XBB.1 subvariants

Meta-analysis reviews the incidence of new-onset diabetes in COVID-19 survivors

The evolutionary trajectories and mechanisms driving the emergence of post-Omicron SARS-CoV-2 lineages

A new use for dating apps: Chasing STIs

Researchers explore gut microbiome dysbiosis in acute COVID-19 infection and recovery

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News